MedPath

Efficacy of Telemetry-assisted Care in Home Home Vented COPD

Not Applicable
Recruiting
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Other: Telemonitoring Care
Other: Standard Care
Registration Number
NCT05287555
Lead Sponsor
Georg Nilius, Prof DR med
Brief Summary

This study in patients suffering of Chronic Obstructive Pulmonary disease (COPD) aims to investigate whether telemonitoring of their non invasive ventilation (NIV) device together with targeted, tailored intervention in case of increasing symptoms or ventilation abnormalities improves the therapy adherence and effectiveness and can reduce the need for hospitalizations.

Detailed Description

54 NIV naive COPD patients will be randomized to either telemonitoring care with a data-based intervention scheme or standard care according to the guideline of the German Society of Pneumology.

Primary objective:

Adherence to ventilation in the intervention group versus control group.

Secondary objective:

Comparisons between the control and intervention groups, over time and against each other, in terms of:

* Health-related quality of life assessed by SGRQ

* Symptomatology based on blood gas analyses, CAT score, mMRC score and S3-NIV score

* Therapy quality according to therapy parameters from device data

* Number of hospitalizations and physician visits

* Evaluation of the impact of feedback and interventions on therapy adherence, symptomatology and therapy data.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
54
Inclusion Criteria
  • NIV-naive / Continuation after 3 Months Interruption
  • Indication for initiation of NIV according to S2k guideline of the German Society of Pneumology
  • Presence of the signed informed consent
Exclusion Criteria
  • Absence of signed written informed consent for data protection and study participation.
  • contraindication to PAP therapy
  • Participation in another study that influences the setting of NIV therapy through specifications regarding device settings or titration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TelemonitoringTelemonitoring CareHome non-invasive mask ventilation with prisma VENT device. Modem for the daily transmission of specific therapy parameters. An electronic feedback system provides patients with feedback and recommendations on their therapy based on the data submitted. The study center regularly reviews and reacts to all therapy data and other information according to the remote care scheme of intervention. Telemonitoring care patients also receive an SpO2 sensor for monitoring of oxygen saturation. Ambulantory implementation of three blood gas analyses to check the health status after 2, 6 and 12 months. There are no regular routine inpatient stays. Study specific: During visits, recording of HRQOL by SGRQ and S3NIV questionnaires, hospitalizaion and physician visits.
ControlStandard CareHome non-invasive mask ventilation with prisma VENT device. Modem for the daily transmission of specific therapy parameters. Standard care according to clinical standard (technical support by the provider and three hospital follow-up appointments after 2, 6 and after 12 months) with assessment of health status and NIV therapy settings. Study specific: During visits, recording of HRQOL by SGRQ and S3NIV questionnaires, hospitalizaion and physician visits. Therapy data from NIV device.
Primary Outcome Measures
NameTimeMethod
Adherence [hours/day]12 Months

Usage of Ventilator in hours per day

Secondary Outcome Measures
NameTimeMethod
QOL [unit]Survey at 3 dates: 2, 6 und 12 Months

Health related Quality of Life by SGRQ-Score \[higher units represent worse outcome\]

Trial Locations

Locations (1)

Evang. Kliniken Essen-Mitte gGmbH

🇩🇪

Essen, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath